Polyglutamate directed coupling of bioactive peptides for the delivery of osteoinductive signals on allograft bone

Biomaterials

Volumn 34, Issue 5, 2013, Pages 1506-1513

  Culpepper, Bonnie K ^a   Bonvallet, Paul P ^b   Reddy, Michael S ^c   Ponnazhagan, Selvarangan ^d   Bellis, Susan L ^a,b  

^a and Radiation Oncology   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

Allograft bone; BMP2; Collagen I; Hydroxyapatite; Osteoinductive peptide

Indexed keywords

BIOACTIVE PEPTIDES; BMP2; BONE MINERALS; BONE TISSUE; COLLAGEN I; IN-VIVO; PEPTIDE LOADING; POLYGLUTAMATE;

BONE; COLLAGEN; DRUG DELIVERY; HYDROXYAPATITE; LOADING; PEPTIDES; TISSUE;

GRAFTS;

ASPARTYLGLYCYLGLUTAMYLALANINE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; HEPTAGLUTAMATE; HYDROXYAPATITE; PEPTIDE; POLYGLUTAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENGINEERING; BONE ALLOGRAFT; BONE DEVELOPMENT; BONE MINERAL; BONE TISSUE; CONTROLLED STUDY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT;

ANIMALS; BONE AND BONES; BONE DEVELOPMENT; BONE TRANSPLANTATION; GLUTAMIC ACID; MALE; MICE; OLIGOPEPTIDES; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84870701627     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.10.046     Document Type: Article

References (66)

1. Giannoudis P.V., Dinopoulos H., Tsiridis E. Bone substitutes: an update. Injury 2005, 36(Suppl. 3):S20-S27.
2. Bostrom M.P., Seigerman D.A. The clinical use of allografts, demineralized bone matrices, synthetic bone graft substitutes and osteoinductive growth factors: a survey study. HSS J 2005, 1:9-18.
3. Lee J.Y., Choi M.H., Shin E.Y., Kang Y.K. Autologous mesenchymal stem cells loaded in gelfoam((r)) for structural bone allograft healing in rabbits. Cell Tissue Bank 2011, 12:299-309.
4. Di Bella C., Aldini N.N., Lucarelli E., Dozza B., Frisoni T., Martini L., et al. Osteogenic protein-1 associated with mesenchymal stem cells promote bone allograft integration. Tissue Eng Part A 2010, 16:2967-2976.
5. Breitbart E.A., Meade S., Azad V., Yeh S., Al-Zube L., Lee Y.S., et al. Mesenchymal stem cells accelerate bone allograft incorporation in the presence of diabetes mellitus. J Orthop Res 2010, 28:942-949.
6. Pantou A.L., Markopoulou C.E., Dereka X.E., Vavouraki H., Mamalis A., Vrotsos I.A. The effect of platelet-rich plasma (prp) combined with a bone allograft on human periodontal ligament (pdl) cells. Cell Tissue Bank 2012, 13:81-88.
7. Messora M., Braga L., Oliveira G., Oliveira L.F., Milagres R., Kawata L., et al. Healing of fresh frozen bone allograft with or without platelet-rich plasma: a histologic and histometric study in rats. Clin Implant Dent Relat Res 2011, Available from URL:. http://www.ncbi.nlm.nih.gov/pubmed/22176648, 10.1111/j.1708-8208.2011.00419.x.
8. Wei L.C., Lei G.H., Sheng P.Y., Gao S.G., Xu M., Jiang W., et al. Efficacy of platelet-rich plasma combined with allograft bone in the management of displaced intra-articular calcaneal fractures: a prospective cohort study. J Orthop Res 2012, 30:1570-1576.
9. Donati D., Di Bella C., Lucarelli E., Dozza B., Frisoni T., Aldini N.N., et al. Op-1 application in bone allograft integration: preliminary results in sheep experimental surgery. Injury 2008, 39(Suppl. 2):S65-S72.
10. Yasuda H., Yano K., Wakitani S., Matsumoto T., Nakamura H., Takaoka K. Repair of critical long bone defects using frozen bone allografts coated with an rhbmp-2-retaining paste. J Orthop Sci 2012, 17:299-307.
11. Fukuroku J., Inoue N., Rafiee B., Sim F.H., Frassica F.J., Chao E.Y. Extracortical bone-bridging fixation with use of cortical allograft and recombinant human osteogenic protein-1. J Bone Jt Surg Am 2007, 89:1486-1496.
12. Rosen P.S., Toscano N., Holzclaw D., Reynolds M.A. A retrospective consecutive case series using mineralized allograft combined with recombinant human platelet-derived growth factor bb to treat moderate to severe osseous lesions. Int J Periodontics Restorative Dent 2011, 31:335-342.
13. Buttermann G.R. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Spine J 2008, 8:426-435.
14. Lewandrowski K.U., Bondre S., Hile D.D., Thompson B.M., Wise D.L., Tomford W.W., et al. Porous poly(propylene fumarate) foam coating of orthotopic cortical bone grafts for improved osteoconduction. Tissue Eng 2002, 8:1017-1027.
15. Lewandrowski K.U., Bondre S.P., Gresser J.D., Wise D.L., Tomford W.W., Trantolo D.J. Improved osteoconduction of cortical bone grafts by biodegradable foam coating. Biomed Mater Eng 1999, 9:265-275.
16. Bondre S., Lewandrowski K.U., Hasirci V., Cattaneo M.V., Gresser J.D., Wise D.L., et al. Biodegradable foam coating of cortical allografts. Tissue Eng 2000, 6:217-227.
17. Huang C., Das A., Barker D., Tholpady S., Wang T., Cui Q., et al. Local delivery of fty720 accelerates cranial allograft incorporation and bone formation. Cell Tissue Res 2012, 347:553-566.
18. Petrie Aronin C.E., Shin S.J., Naden K.B., Rios P.D., Sefcik L.S., Zawodny S.R., et al. The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug fty720. Biomaterials 2010, 31:6417-6424.
19. Murphy M.B., Hartgerink J.D., Goepferich A., Mikos A.G. Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties. Biomacromolecules 2007, 8:2237-2243.
20. Itoh D., Yoneda S., Kuroda S., Kondo H., Umezawa A., Ohya K., et al. Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (eeeeeeeprgdt) in vitro. J Biomed Mater Res 2002, 62:292-298.
21. Fujisawa R., Mizuno M., Nodasaka Y., Kuboki Y. Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (glu7-pro-arg-gly-asp-thr) containing two functional sequences of bone sialoprotein. Matrix Biol 1997, 16:21-28.
22. Gilbert M., Giachelli C.M., Stayton P.S. Biomimetic peptides that engage specific integrin-dependent signaling pathways and bind to calcium phosphate surfaces. J Biomed Mater Res A 2003, 67:69-77.
23. Gilbert M., Shaw W.J., Long J.R., Nelson K., Drobny G.P., Giachelli C.M., et al. Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion. J Biol Chem 2000, 275:16213-16218.
24. Lee J.S., Lee J.S., Murphy W.L. Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces. Acta Biomater 2010, 6:21-28.
25. Sawyer A.A., Hennessy K.M., Bellis S.L. The effect of adsorbed serum proteins, rgd and proteoglycan-binding peptides on the adhesion of mesenchymal stem cells to hydroxyapatite. Biomaterials 2007, 28:383-392.
26. Sawyer A.A., Weeks D.M., Kelpke S.S., McCracken M.S., Bellis S.L. The effect of the addition of a polyglutamate motif to rgd on peptide tethering to hydroxyapatite and the promotion of mesenchymal stem cell adhesion. Biomaterials 2005, 26:7046-7056.
27. Culpepper B.K., Phipps M.C., Bonvallet P.P., Bellis S.L. Enhancement of peptide coupling to hydroxyapatite and implant osseointegration through collagen mimetic peptide modified with a polyglutamate domain. Biomaterials 2010, 31:9586-9594.
28. Ganss B., Kim R.H., Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med 1999, 10:79-98.
29. Hoang Q.Q., Sicheri F., Howard A.J., Yang D.S. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 2003, 425:977-980.
30. Stayton P.S., Drobny G.P., Shaw W.J., Long J.R., Gilbert M. Molecular recognition at the protein-hydroxyapatite interface. Crit Rev Oral Biol Med 2003, 14:370-376.
31. Mizuno M., Fujisawa R., Kuboki Y. Type i collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-alpha2beta1 integrin interaction. J Cell Physiol 2000, 184:207-213.
32. Mizuno M., Kuboki Y. Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type i collagen. J Biochem 2001, 129:133-138.
33. Takeuchi Y., Suzawa M., Kikuchi T., Nishida E., Fujita T., Matsumoto T. Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem 1997, 272:29309-29316.
34. Xiao G., Wang D., Benson M.D., Karsenty G., Franceschi R.T. Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the osf2 transcription factor. J Biol Chem 1998, 273:32988-32994.
35. Hennessy K.M., Pollot B.E., Clem W.C., Phipps M.C., Sawyer A.A., Culpepper B.K., et al. The effect of collagen i mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials 2009, 30:1898-1909.
36. Anderson J.M., Kushwaha M., Tambralli A., Bellis S.L., Camata R.P., Jun H.W. Osteogenic differentiation of human mesenchymal stem cells directed by extracellular matrix-mimicking ligands in a biomimetic self-assembled peptide amphiphile nanomatrix. Biomacromolecules 2009, 10:2935-2944.
37. Yang X.B., Bhatnagar R.S., Li S., Oreffo R.O. Biomimetic collagen scaffolds for human bone cell growth and differentiation. Tissue Eng 2004, 10:1148-1159.
38. Ripamonti U., Crooks J., Khoali L., Roden L. The induction of bone formation by coral-derived calcium carbonate/hydroxyapatite constructs. Biomaterials 2009, 30:1428-1439.
39. Gomar F., Orozco R., Villar J.L., Arrizabalaga F. P-15 small peptide bone graft substitute in the treatment of non-unions and delayed union. A pilot clinical trial. Int Orthop 2007, 31:93-99.
40. Valentin A.H., Weber J. Receptor technology-cell binding to p-15: a new method of regenerating bone quickly and safely-preliminary histomorphometrical and mechanical results in sinus floor augmentations. Keio J Med 2004, 53:166-171.
41. Reyes C.D., Garcia A.J. Alpha2beta1 integrin-specific collagen-mimetic surfaces supporting osteoblastic differentiation. J Biomed Mater Res A 2004, 69:591-600.
42. Reyes C.D., Petrie T.A., Burns K.L., Schwartz Z., Garcia A.J. Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials 2007, 28:3228-3235.
43. Wojtowicz A.M., Shekaran A., Oest M.E., Dupont K.M., Templeman K.L., Hutmacher D.W., et al. Coating of biomaterial scaffolds with the collagen-mimetic peptide gfoger for bone defect repair. Biomaterials 2010, 31:2574-2582.
44. Knight C.G., Morton L.F., Onley D.J., Peachey A.R., Messent A.J., Smethurst P.A., et al. Identification in collagen type i of an integrin alpha2 beta1-binding site containing an essential ger sequence. J Biol Chem 1998, 273:33287-33294.
45. Knight C.G., Morton L.F., Peachey A.R., Tuckwell D.S., Farndale R.W., Barnes M.J. The collagen-binding a-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, gfoger, in native (triple-helical) collagens. J Biol Chem 2000, 275:35-40.
46. Emsley J., Knight C.G., Farndale R.W., Barnes M.J. Structure of the integrin alpha2beta1-binding collagen peptide. J Mol Biol 2004, 335:1019-1028.
47. Staatz W.D., Fok K.F., Zutter M.M., Adams S.P., Rodriguez B.A., Santoro S.A. Identification of a tetrapeptide recognition sequence for the alpha 2 beta 1 integrin in collagen. J Biol Chem 1991, 266:7363-7367.
48. Saito A., Suzuki Y., Ogata S., Ohtsuki C., Tanihara M. Accelerated bone repair with the use of a synthetic bmp-2-derived peptide and bone-marrow stromal cells. J Biomed Mater Res A 2005, 72:77-82.
49. Poh C.K., Shi Z., Tan X.W., Liang Z.C., Foo X.M., Tan H.C., et al. Cobalt chromium alloy with immobilized bmp peptide for enhanced bone growth. J Orthop Res 2011, 29:1424-1430.
50. Pluhar G.E., Manley P.A., Heiner J.P., Vanderby R., Seeherman H.J., Markel M.D. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model. J Orthop Res 2001, 19:308-317.
51. Belfrage O., Flivik G., Sundberg M., Kesteris U., Tagil M. Local treatment of cancellous bone grafts with bmp-7 and zoledronate increases both the bone formation rate and bone density: a bone chamber study in rats. Acta Orthop 2011, 82:228-233.
52. McKay W.F., Peckham S.M., Badura J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (infuse bone graft). Int Orthop 2007, 31:729-734.
53. White A.P., Vaccaro A.R., Hall J.A., Whang P.G., Friel B.C., McKee M.D. Clinical applications of bmp-7/op-1 in fractures, nonunions and spinal fusion. Int Orthop 2007, 31:735-741.
54. LeBaron R.G., Athanasiou K.A. Extracellular matrix cell adhesion peptides: functional applications in orthopedic materials. Tissue Eng 2000, 6:85-103.
55. 2 nanotubes functionalized with regions of bone morphogenetic protein-2 increases osteoblast adhesion. J Biomed Mater Res A 2008, 84:447-453.
56. Choi J.Y., Jung U.W., Kim C.S., Eom T.K., Kang E.J., Cho K.S., et al. The effects of newly formed synthetic peptide on bone regeneration in rat calvarial defects. J Periodontal Implant Sci 2010, 40:11-18.
57. Shen H., Hu X., Yang F., Bei J., Wang S. The bioactivity of rhbmp-2 immobilized poly(lactide-co-glycolide) scaffolds. Biomaterials 2009, 30:3150-3157.
58. Schuessele A., Mayr H., Tessmar J., Goepferich A. Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces. J Biomed Mater Res A 2009, 90:959-971.
59. Zouani O.F., Chollet C., Guillotin B., Durrieu M.C. Differentiation of pre-osteoblast cells on poly(ethylene terephthalate) grafted with rgd and/or bmps mimetic peptides. Biomaterials 2010, 31:8245-8253.
60. Ketonis C., Barr S., Shapiro I.M., Parvizi J., Adams C.S., Hickok N.J. Antibacterial activity of bone allografts: comparison of a new vancomycin-tethered allograft with allograft loaded with adsorbed vancomycin. Bone 2011, 48:631-638.
61. Smucker J.D., Bobst J.A., Petersen E.B., Nepola J.V., Fredericks D.C. B2a peptide on ceramic granules enhance posterolateral spinal fusion in rabbits compared with autograft. Spine 2008, 33:1324-1329.
62. Cunningham B.W., Atkinson B.L., Hu N., Kikkawa J., Jenis L., Bryant J., et al. Ceramic granules enhanced with b2a peptide for lumbar interbody spine fusion: an experimental study using an instrumented model in sheep. J Neurosurg Spine 2009, 10:300-307.
63. Yokogawa K., Miya K., Sekido T., Higashi Y., Nomura M., Fujisawa R., et al. Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice. Endocrinology 2001, 142:1228-1233.
64. Yokogawa K., Toshima K., Yamoto K., Nishioka T., Sakura N., Miyamoto K. Pharmacokinetic advantage of an intranasal preparation of a novel anti-osteoporosis drug, l-asp-hexapeptide-conjugated estradiol. Biol Pharm Bull 2006, 29:1229-1233.
65. Kasugai S., Fujisawa R., Waki Y., Miyamoto K., Ohya K. Selective drug delivery system to bone: small peptide (asp)6 conjugation. J Bone Miner Res 2000, 15:936-943.
66. Takahashi T., Yokogawa K., Sakura N., Nomura M., Kobayashi S., Miyamoto K. Bone-targeting of quinolones conjugated with an acidic oligopeptide. Pharm Res 2008, 25:2881-2888.